RxDoctor Payments Data

Karensa Franklin, MD

Family Medicine · Roswell, GANPI 1528418340

Payments from drug & device makers

$1,142in general payments, 2019–2025

Across 40 payments — averaging $28.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$230
  • Sanofi Pasteur Inc.$140
  • GSK$131
  • Tactile Systems Technology Inc$116
  • Sanofi-aventis U.S. LLC$87
  • Amgen$82
  • plus $356 from 9 others

What the payments were for

  • Food & beverage$1,13099%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,142 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$39,005
Medicare patients
130
Services billed
605

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$88,258
EliquisApixaban59$81,881
MounjaroTirzepatide48$65,637
JardianceEmpagliflozin29$42,330
TrulicityDulaglutide26$33,984
RybelsusSemaglutide17$19,454
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$17,962
KerendiaFinerenone16$15,837
JanuviaSitagliptin Phosphate14$15,837
Janumet XrSitagliptin Phos/Metformin Hcl11$11,989
Synjardy XrEmpagliflozin/Metformin Hcl12$7,449
Rosuvastatin Calcium183$4,555
Atorvastatin Calcium209$3,991
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,786
Arnuity ElliptaFluticasone Furoate11$3,671

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$52$107,71363 claims
Lilly USA, LLCMounjaro, Trulicity$230$99,62274 claims
PfizerEliquis$51$81,88159 claims
GSKTrelegy Ellipta, Arnuity Ellipta$131$21,63332 claims
BayerKerendia$69$15,83716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Roswell

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →